Ustekinumab is a medication used in this clinical trial. It is designed to help manage certain inflammatory conditions by targeting specific proteins in the immune system that can cause inflammation. This medication is often used to treat conditions like psoriasis, psoriatic arthritis, and Crohn’s disease. In this trial, the focus is on understanding the long-term safety of using Ustekinumab in children and teenagers who are between 2 and 18 years old. The goal is to see how well the medication works over a longer period and to ensure it is safe for young patients to use. Participants in the trial will receive Ustekinumab to help control their symptoms and improve their quality of life while researchers monitor any side effects or issues that may arise during the study.

Crohn’s Disease – Crohn’s Disease is a chronic inflammatory condition of the gastrointestinal tract. It can affect any part of the digestive system, from the mouth to the anus, but most commonly impacts the end of the small intestine and the beginning of the colon. The inflammation can penetrate deep into the layers of the bowel tissue, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The disease often progresses with periods of remission and flare-ups. Over time, it can cause complications like strictures, fistulas, and abscesses. The exact cause of Crohn’s Disease is unknown, but it involves an abnormal immune response.

Juvenile Psoriatic Arthritis – Juvenile Psoriatic Arthritis is a type of inflammatory arthritis that affects children and is associated with the skin condition psoriasis. It causes joint pain, swelling, and stiffness, often in the fingers and toes, and can also lead to changes in the nails. The disease can progress to involve larger joints and the spine. Symptoms may appear in cycles, with periods of increased activity followed by times of remission. The skin symptoms of psoriasis, such as red patches with silvery scales, may precede or follow the onset of arthritis. The exact cause is not fully understood, but it involves genetic and immune system factors.

Ulcerative Colitis – Ulcerative Colitis is a chronic inflammatory condition that affects the colon and rectum. It causes inflammation and ulcers in the innermost lining of the large intestine, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding. The disease typically begins in the rectum and may extend continuously to involve the entire colon. The progression of Ulcerative Colitis is marked by periods of exacerbation and remission. Over time, it can lead to complications such as severe bleeding, perforation of the colon, and increased risk of colon cancer. The exact cause is unknown, but it involves an abnormal immune response in the gut.